Compare ALLO & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | DDL |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 494.2M |
| IPO Year | 2018 | 2021 |
| Metric | ALLO | DDL |
|---|---|---|
| Price | $0.76 | $1.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 11.2M | 297.6K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | $72.02 | $9.66 |
| P/E Ratio | ★ N/A | $16.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.74 | $1.69 |
| 52 Week High | $4.46 | $3.41 |
| Indicator | ALLO | DDL |
|---|---|---|
| Relative Strength Index (RSI) | 21.26 | 33.65 |
| Support Level | N/A | N/A |
| Resistance Level | $2.25 | $2.58 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 0.42 | 6.67 |
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Dingdong (Cayman) Ltd are a foremost fresh grocery e-commerce company in mainland China with sustainable growth. It directly provide users and households with fresh groceries, prepared food and other food products through delivering a convenient and excellent shopping experience supported by an extensive self-operated frontline fulfillment grid. The Group operates and manages its business as a single segment. The Group generates substantially all of its revenues from customers in the PRC.